Related Experiment Video
Updated: Jun 8, 2026

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
Published on: December 26, 2019
Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to
Nami Sugiyama1, Markku Varjosalo, Pipsa Meller
1Molecular Cancer Biology Research Program, Departments of Pathology and Virology, Haartman Institute, Helsinki, Finland.
Abstract:
Aberrant expression and polymorphism of fibroblast growth factor receptor 4 (FGFR4) has been linked to tumor progression and anticancer drug resistance. We describe here a novel mechanism of tumor progression by matrix degradation involving epithelial-to-mesenchymal transition in response to membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14) induction at the edge of tumors expressing the FGFR4-R388 risk variant. Both FGFR4 and MT1-MMP were upregulated in tissue biopsies from several human cancer types including breast adenocarcinomas, where they were partially coexpressed at the tumor/stroma border and tumor invasion front. The strongest overall coexpression was found in prostate carcinoma. Studies with cultured prostate carcinoma cell lines showed that the FGFR4-R388 variant, which has previously been associated with poor cancer prognosis, increased MT1-MMP-dependent collagen invasion. In this experimental model, knockdown of FGFR4-R388 or MT1-MMP by RNA interference blocked tumor cell invasion and growth in collagen. This was coupled with impaired phosphorylation of FGFR substrate 2 and Src, upregulation of E-cadherin, and suppression of cadherin-11 and N-cadherin. These in vitro results were substantiated by reduced MT1-MMP content and in vivo growth of prostate carcinoma cells after the FGFR4-R388 gene silencing. In contrast, knockdown of the alternative FGFR4-G388 allele enhanced MT1-MMP and invasive tumor cell growth in vivo and within three-dimensional collagen. These results will help to explain the reported association of the FGFR4-R388 variant with the progression and poor prognosis of certain types of tumors.
Insights
The FGFR4-R388 gene variant promotes cancer progression by increasing matrix degradation and invasion, while the FGFR4-G388 allele has the opposite effect. This explains the link between FGFR4-R388 and poor cancer prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aberrant fibroblast growth factor receptor 4 (FGFR4) expression and genetic variations are implicated in tumor progression and resistance to cancer therapies.
- The FGFR4-R388 risk variant is associated with poor cancer prognosis.
- Membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a role in extracellular matrix degradation and tumor invasion.
Purpose of the Study:
- To elucidate a novel mechanism of tumor progression involving matrix degradation and epithelial-to-mesenchymal transition.
- To investigate the role of the FGFR4-R388 variant in MT1-MMP induction and tumor cell invasion.
- To explore the impact of FGFR4 variants on cancer cell behavior and prognosis.
Main Methods:
- Analysis of FGFR4 and MT1-MMP expression in human cancer biopsies (breast, prostate).
- In vitro studies using cultured prostate carcinoma cell lines with FGFR4-R388 and FGFR4-G388 variants.
- RNA interference (RNAi) to knockdown FGFR4-R388, FGFR4-G388, or MT1-MMP.
- Assessment of tumor cell invasion, growth, and molecular signaling pathways (FGFR substrate 2, Src, cadherins).
- In vivo studies to evaluate tumor growth and MT1-MMP content after gene silencing.
Main Results:
- FGFR4 and MT1-MMP were upregulated and coexpressed at invasive fronts in various human cancers, notably prostate carcinoma.
- The FGFR4-R388 variant enhanced MT1-MMP-dependent collagen invasion and tumor growth.
- Knockdown of FGFR4-R388 or MT1-MMP inhibited tumor cell invasion and growth, with associated molecular changes (e.g., E-cadherin upregulation).
- Conversely, knockdown of the FGFR4-G388 allele increased MT1-MMP and invasive tumor cell growth.
Conclusions:
- The FGFR4-R388 variant drives tumor progression through MT1-MMP induction and matrix degradation, contributing to poor prognosis.
- FGFR4-R388 and MT1-MMP are key players in cancer cell invasion and growth.
- Understanding the differential roles of FGFR4 alleles (R388 vs. G388) provides insights into cancer progression mechanisms and potential therapeutic targets.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
The Tumor Microenvironment
TGF - β Signaling Pathway
Cancer Cell Migration through Invadopodia

